Risk of Paradoxical Eczema in Patients Receiving Biologics for Psoriasis
JAMA Dermatology, 2023.
Ali Al-Janabi; Oras A. Alabas; Zenas Z. N. Yiu; Amy C. Foulkes; Steve Eyre; Adnan R. Khan; Nick J. Reynolds; Catherine H. Smith; Christopher E. M. Griffiths; Richard B. Warren; the BADBIR Study Group.
Read publication: JAMA Dermatology
Related
Effectiveness and persistence of acitretin, ciclosporin, fumaric acid esters and methotrexate for pa...
Drug Survival Associated With Effectiveness and Safety of Treatment With Guselkumab, Ixekizumab, Sec...
The British Association of Dermatologists Biologics and Immunomodulators Register: a centenary celeb...
Contact Us
Find Us
The University of Manchester
First Floor Bright Building
Manchester Science Park
Manchester
M15 6GZ
0 Comments